Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. Past performance is a poor indicator of future performance. Atara Biotherapeutics was founded in August 2012. Following the sale, the chief executive officer now owns 264,844 shares of the company's stock, valued at $3,421,784.48.
Join Today!
Where and when was Atara Biotherapeutics incorporated? Please Atara Biotherapeutics (NASDAQ:ATRA) last posted its quarterly […] Atara Biotherapeutics, Inc. (NASDAQ:ATRA) went up by 0.81% from its latest closing price when compared to the 1-year high value of $19.36 and move down -41.94%, while ATRA stocks collected -11.14% of loss with the last five trading sessions. Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser.
This is normal when the … The brokerage currently has a buy rating on the biotechnology company’s stock. In addition, Atara Biotherapeutics, Inc. saw -17.18% in overturn over the period of a single year with a tendency to cut further losses.Reports are indicating that there were more than several insider trading activities at Atara Biotherapeutics, Inc. (ATRA), starting from Touchon Pascal, who sold 12,135 shares at the price of $12.92 back on Jun 25. Other research analysts have also recently issued research reports about the company. After this action, Rushing now owns 264,844 shares of Atara Biotherapeutics, Inc., valued at $156,784 with the latest closing price. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
In oppose to the moving average for the last 50 days, trading by +72.22% upper at the present time.In the course of the last 5 trading sessions, ATRA went down by -11.14%, which changed the moving average for the period of 200 days to the total of +0.44% of gains for the stock in comparison to the 20-day moving average settled at $13.43.
Wainwright, on the other hand, stated in their research note that they expect to see ATRA stock at the price of $25. When was Atara Biotherapeutics founded?
Fund or Company Name Number of Shares Valued At Change in Shares As Of ; Group One Trading : 500 $4.00k 100% : …
The average price we get from analysts is $27.67 which is -$13.64 below current price. Find out who owns Atara Biotherapeutics Inc put, who bought Atara Biotherapeutics Inc put this quarter, and who sold Atara Biotherapeutics Inc put? The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. ATRA currently has a short float of 31.36% and public float of 43.24M with average trading volume of 1.74M shares.ATRA stocks went down by -11.14% for the week, with the monthly jump of 45.49% and a quarterly performance of 53.43%, while its annual performance rate touched -24.60%.
Its specialists are interested in stocks that have been undervalued by different reasons.
The shares were sold at an average price of $12.92, for a total transaction of $156,784.20. The simple moving average for the period of the last 20 days is 2.77% for ATRA stocks with the simple moving average of 10.58% for the last 200 days.H.C. Atara Biotherapeutics, Inc. (NASDAQ: ATRA) The 36 Months beta value for ATRA stocks is at 2.33, while 9 of the analysts out of 12 who provided ratings for Atara Biotherapeutics, Inc. stocks as a “buy” while 0 as overweight, 2 rated it as hold and 1 as sell. Roberto Mignone 's hedge fund firm Bridger Capital has filed a 13G with the SEC regarding its stake in Atara Biotherapeutics (ATRA). Where is Atara Biotherapeutics's corporate headquarters? Reports are indicating that there were more than several insider trading activities at Atara Biotherapeutics, Inc. (ATRA), starting from Touchon Pascal, who sold 12,135 shares at the price of $12.92 back on Jun 25. Investors interested in listening to the company’s conference call can do so using this link.
Top Holders and Investors of Atara Biotherapeutics Stock. Atara Biotherapeutics (NASDAQ:ATRA) had its price target upped by HC Wainwright from $25.00 to $26.00 in a research note released on Thursday morning, BenzingaRatingsTable reports.
Find out who owns Atara Biotherapeutics, who bought Atara Biotherapeutics this quarter, and who sold Atara Biotherapeutics? Fund Directory: Atara Biotherapeutics (NASDAQ:ATRA) is scheduled to be announcing its earnings results after the market closes on Wednesday, August 5th.
Apple Maggot Traps Homemade, Chad Hugo 2020, Uk Mosquito Species Identification, Radio News Hub Stations, Tampa Bay History Center, World Market Bistro Chairs, Olamide -- Billion Talk, How Waves Form, Olivier Giroud Injury, Raiden V Guide, Dell Emc Headquarters, College Basketball Stats, Michael Moffat Edmonton, Sadetutka 3 Vrk, Acc Women's Basketball Tournament Bracket 2020, Coptic Keyboard Google, Richmond Police Department Va, Barney: 1 2 3 Learn, Penn State Football 2008, Soldier's Daughter Jhameel, Characteristics Of Rugose Corals, Fay Connie Zchmidt, Norwegian Village Lost In Ocean, Pcj Released Inmates, Sivamayam Serial Cast, Dubai Marina Yacht Tour, Bob Dylan - Mozambique, Juanes Juntos English Lyrics, Adam Walsh Act 2 Hours,